{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:45:29Z","timestamp":1791096329656,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Giant Axonal Neuropathy (GAN) is a fatal neurodegenerative disorder with early onset characterized by a severe deterioration of the peripheral and central nervous system, involving both the motor and the sensory tracts and leading to ataxia, speech defect and intellectual disabilities. The broad deterioration of the nervous system is accompanied by a generalized disorganization of the intermediate filaments, including neurofilaments in neurons, but the implication of this defect in disease onset or progression remains unknown. The identification of gigaxonin, the substrate adaptor of an E3 ubiquitin ligase, as the defective protein in GAN allows us to now investigate the crucial role of the gigaxonin-E3 ligase in sustaining neuronal and intermediate filament integrity. To study the mechanisms controlled by gigaxonin in these processes and to provide a relevant model to test the therapeutic approaches under development for GAN, we generated a Gigaxonin-null mouse by gene targeting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We investigated for the first time in Gigaxonin-null mice the deterioration of the motor and sensory functions over time as well as the spatial disorganization of neurofilaments. We showed that gigaxonin depletion in mice induces mild but persistent motor deficits starting at 60 weeks of age in the 129\/SvJ-genetic background, while sensory deficits were demonstrated in C57BL\/6 animals. In our hands, another gigaxonin-null mouse did not display the early and severe motor deficits reported previously. No apparent neurodegeneration was observed in our knock-out mice, but dysregulation of neurofilaments in proximal and distal axons was massive. Indeed, neurofilaments were not only more abundant but they also showed the abnormal increase in diameter and misorientation that are characteristics of the human pathology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Together, our results show that gigaxonin depletion in mice induces mild motor and sensory deficits but recapitulates the severe neurofilament dysregulation seen in patients. Our model will allow investigation of the role of the gigaxonin-E3 ligase in organizing neurofilaments and may prove useful in understanding the pathological processes engaged in other neurodegenerative disorders characterized by accumulation of neurofilaments and dysfunction of the Ubiquitin Proteasome System, such as Amyotrophic Lateral Sclerosis, Huntington's, Alzheimer's and Parkinson's diseases.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1750-1326-6-25","type":"journal-article","created":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T06:22:24Z","timestamp":1302675744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice"],"prefix":"10.1186","volume":"6","author":[{"given":"Thibault","family":"Ganay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Boizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Burrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Bomont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,12]]},"reference":[{"key":"181_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF00686905","volume":"20","author":"AK Asbury","year":"1972","unstructured":"Asbury AK, Gale MK, Cox SC, Baringer JR, Berg BO: Giant axonal neuropathy: a unique case with segmental neurofilamentous masses. Acta Neuropathol. 1972, 20: 237-247. 10.1007\/BF00686905.","journal-title":"Acta Neuropathol"},{"key":"181_CR2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1542\/peds.49.6.894","volume":"49","author":"BO Berg","year":"1972","unstructured":"Berg BO, Rosenberg SH, Asbury AK: Giant axonal neuropathy. Pediatrics. 1972, 49: 894-899.","journal-title":"Pediatrics"},{"key":"181_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0387-7604(89)80038-5","volume":"11","author":"RA Ouvrier","year":"1989","unstructured":"Ouvrier RA: Giant axonal neuropathy. A review. Brain Dev. 1989, 11: 207-214.","journal-title":"Brain Dev"},{"key":"181_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF01674207","volume":"17","author":"M Donaghy","year":"1988","unstructured":"Donaghy M, King RH, Thomas PK, Workman JM: Abnormalities of the axonal cytoskeleton in giant axonal neuropathy. J Neurocytol. 1988, 17: 197-208. 10.1007\/BF01674207.","journal-title":"J Neurocytol"},{"key":"181_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000116646","volume":"31","author":"GC Guazzi","year":"1991","unstructured":"Guazzi GC, Malandrini A, Gerli R, Federico A: Giant axonal neuropathy in 2 siblings: a generalized disorder of intermediate filaments. Eur Neurol. 1991, 31: 50-56. 10.1159\/000116646.","journal-title":"Eur Neurol"},{"key":"181_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0387-7604(98)00056-4","volume":"20","author":"I Mohri","year":"1998","unstructured":"Mohri I, Taniike M, Yoshikawa H, Higashiyama M, Itami S, Okada S: A case of giant axonal neuropathy showing focal aggregation and hypophosphorylation of intermediate filaments. Brain Dev. 1998, 20: 594-597. 10.1016\/S0387-7604(98)00056-4.","journal-title":"Brain Dev"},{"key":"181_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/neu.10270","volume":"58","author":"RC Lariviere","year":"2004","unstructured":"Lariviere RC, Julien JP: Functions of intermediate filaments in neuronal development and disease. J Neurobiol. 2004, 58: 131-148. 10.1002\/neu.10270.","journal-title":"J Neurobiol"},{"key":"181_CR8","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1212\/WNL.31.11.1470","volume":"31","author":"SD Pena","year":"1981","unstructured":"Pena SD: Giant axonal neuropathy: intermediate filament aggregates in cultured skin fibroblasts. Neurology. 1981, 31: 1470-1473.","journal-title":"Neurology"},{"key":"181_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/00005072-197607000-00006","volume":"35","author":"JW Prineas","year":"1976","unstructured":"Prineas JW, Ouvrier RA, Wright RG, Walsh JC, McLeod JG: Gian axonal neuropathy: a generalized disorder of cytoplasmic microfilament formation. J Neuropathol Exp Neurol. 1976, 35: 458-470. 10.1097\/00005072-197607000-00006.","journal-title":"J Neuropathol Exp Neurol"},{"key":"181_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/hmg\/ddg092","volume":"12","author":"P Bomont","year":"2003","unstructured":"Bomont P, Koenig M: Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization. Hum Mol Genet. 2003, 12: 813-822. 10.1093\/hmg\/ddg092.","journal-title":"Hum Mol Genet"},{"key":"181_CR11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/hmg\/ddp044","volume":"18","author":"DW Cleveland","year":"2009","unstructured":"Cleveland DW, Yamanaka K, Bomont P: Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway. Hum Mol Genet. 2009, 18: 1384-1394. 10.1093\/hmg\/ddp044.","journal-title":"Hum Mol Genet"},{"key":"181_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/81701","volume":"26","author":"P Bomont","year":"2000","unstructured":"Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, Demir E, Topaloglu H, Korinthenberg R, Tuysuz B, et al: The gene encoding gigaxonin, a new member of the cytoskeletal BTB\/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet. 2000, 26: 370-374. 10.1038\/81701.","journal-title":"Nat Genet"},{"key":"181_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/humu.9122","volume":"21","author":"P Bomont","year":"2003","unstructured":"Bomont P, Ioos C, Yalcinkaya C, Korinthenberg R, Vallat JM, Assami S, Munnich A, Chabrol B, Kurlemann G, Tazir M, Koenig M: Identification of seven novel mutations in the GAN gene. Hum Mutat. 2003, 21: 446-10.1002\/humu.9122.","journal-title":"Hum Mutat"},{"key":"181_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1212\/01.WNL.0000101676.41505.A7","volume":"62","author":"C Bruno","year":"2004","unstructured":"Bruno C, Bertini E, Federico A, Tonoli E, Lispi ML, Cassandrini D, Pedemonte M, Santorelli FM, Filocamo M, Dotti MT, et al: Clinical and molecular findings in patients with giant axonal neuropathy (GAN). Neurology. 2004, 62: 13-16.","journal-title":"Neurology"},{"key":"181_CR15","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1002\/ajmg.a.33508","volume":"152A","author":"K Buysse","year":"2010","unstructured":"Buysse K, Vergult S, Mussche S, Ceuterick-de Groote C, Speleman F, Menten B, Lissens W, Van Coster R: Giant axonal neuropathy caused by compound heterozygosity for a maternally inherited microdeletion and a paternal mutation within the GAN gene. Am J Med Genet A. 2010, 152A: 2802-2804. 10.1002\/ajmg.a.33508.","journal-title":"Am J Med Genet A"},{"key":"181_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jnnp.2003.035162","volume":"76","author":"E Demir","year":"2005","unstructured":"Demir E, Bomont P, Erdem S, Cavalier L, Demirci M, Kose G, Muftuoglu S, Cakar AN, Tan E, Aysun S, et al: Giant axonal neuropathy: clinical and genetic study in six cases. J Neurol Neurosurg Psychiatry. 2005, 76: 825-832. 10.1136\/jnnp.2003.035162.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"181_CR17","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/jnnp.2007.118968","volume":"78","author":"H Houlden","year":"2007","unstructured":"Houlden H, Groves M, Miedzybrodzka Z, Roper H, Willis T, Winer J, Cole G, Reilly MM: New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy. J Neurol Neurosurg Psychiatry. 2007, 78: 1267-1270. 10.1136\/jnnp.2007.118968.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"181_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.nmd.2007.03.012","volume":"17","author":"O Koop","year":"2007","unstructured":"Koop O, Schirmacher A, Nelis E, Timmerman V, De Jonghe P, Ringelstein B, Rasic VM, Evrard P, Gartner J, Claeys KG, et al: Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN). Neuromuscul Disord. 2007, 17: 624-630. 10.1016\/j.nmd.2007.03.012.","journal-title":"Neuromuscul Disord"},{"key":"181_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.58.8.1273","volume":"58","author":"G Kuhlenbaumer","year":"2002","unstructured":"Kuhlenbaumer G, Young P, Oberwittler C, Hunermund G, Schirmacher A, Domschke K, Ringelstein B, Stogbauer F: Giant axonal neuropathy (GAN): case report and two novel mutations in the gigaxonin gene. Neurology. 2002, 58: 1273-1276.","journal-title":"Neurology"},{"key":"181_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2156-8-6","volume":"8","author":"CL Leung","year":"2007","unstructured":"Leung CL, Pang Y, Shu C, Goryunov D, Liem RK: Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients. BMC Genet. 2007, 8: 6-10.1186\/1471-2156-8-6.","journal-title":"BMC Genet"},{"key":"181_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ejmg.2008.05.006","volume":"51","author":"GN A Nalini","year":"2008","unstructured":"Nalini GN, Yasha TC, Ravishankar S, Urtizberea A, Huehne K, Rautenstrauss B: Clinical, pathological and molecular findings in two siblings with giant axonal neuropathy (GAN): report from India. Eur J Med Genet. 2008, 51: 426-435. 10.1016\/j.ejmg.2008.05.006.","journal-title":"Eur J Med Genet"},{"key":"181_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.nmd.2009.01.011","volume":"19","author":"M Tazir","year":"2009","unstructured":"Tazir M, Nouioua S, Magy L, Huehne K, Assami S, Urtizberea A, Grid D, Hamadouche T, Rautenstrauss B, Vallat JM: Phenotypic variability in giant axonal neuropathy. Neuromuscul Disord. 2009, 19: 270-274. 10.1016\/j.nmd.2009.01.011.","journal-title":"Neuromuscul Disord"},{"key":"181_CR23","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1177\/0883073809332703","volume":"24","author":"LP Zhang","year":"2009","unstructured":"Zhang LP, Zou LP: Clinical and genetic studies in a Chinese family with giant axonal neuropathy. J Child Neurol. 2009, 24: 1552-1556. 10.1177\/0883073809332703.","journal-title":"J Child Neurol"},{"key":"181_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392: 605-608. 10.1038\/33416.","journal-title":"Nature"},{"key":"181_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ncb1056","volume":"5","author":"M Furukawa","year":"2003","unstructured":"Furukawa M, He YJ, Borchers C, Xiong Y: Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat Cell Biol. 2003, 5: 1001-1007. 10.1038\/ncb1056.","journal-title":"Nat Cell Biol"},{"key":"181_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature01959","volume":"425","author":"L Pintard","year":"2003","unstructured":"Pintard L, Willis JH, Willems A, Johnson JL, Srayko M, Kurz T, Glaser S, Mains PE, Tyers M, Bowerman B, Peter M: The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature. 2003, 425: 311-316. 10.1038\/nature01959.","journal-title":"Nature"},{"key":"181_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature01985","volume":"425","author":"L Xu","year":"2003","unstructured":"Xu L, Wei Y, Reboul J, Vaglio P, Shin TH, Vidal M, Elledge SJ, Harper JW: BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature. 2003, 425: 316-321. 10.1038\/nature01985.","journal-title":"Nature"},{"key":"181_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature04256","volume":"438","author":"E Allen","year":"2005","unstructured":"Allen E, Ding J, Wang W, Pramanik S, Chou J, Yau V, Yang Y: Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature. 2005, 438: 224-228. 10.1038\/nature04256.","journal-title":"Nature"},{"key":"181_CR29","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/hmg\/ddl069","volume":"15","author":"J Ding","year":"2006","unstructured":"Ding J, Allen E, Wang W, Valle A, Wu C, Nardine T, Cui B, Yi J, Taylor A, Jeon NL, et al: Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Hum Mol Genet. 2006, 15: 1451-1463. 10.1093\/hmg\/ddl069.","journal-title":"Hum Mol Genet"},{"key":"181_CR30","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.cub.2005.10.052","volume":"15","author":"W Wang","year":"2005","unstructured":"Wang W, Ding J, Allen E, Zhu P, Zhang L, Vogel H, Yang Y: Gigaxonin interacts with tubulin folding cofactor B and controls its degradation through the ubiquitin-proteasome pathway. Curr Biol. 2005, 15: 2050-2055. 10.1016\/j.cub.2005.10.052.","journal-title":"Curr Biol"},{"key":"181_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1471-4159.2008.05601.x","volume":"107","author":"F Dequen","year":"2008","unstructured":"Dequen F, Bomont P, Gowing G, Cleveland DW, Julien JP: Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1. J Neurochem. 2008, 107: 253-264. 10.1111\/j.1471-4159.2008.05601.x.","journal-title":"J Neurochem"},{"key":"181_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/088307389000500316","volume":"5","author":"K Kumar","year":"1990","unstructured":"Kumar K, Barre P, Nigro M, Jones MZ: Giant axonal neuropathy: clinical, electrophysiologic, and neuropathologic features in two siblings. J Child Neurol. 1990, 5: 229-234. 10.1177\/088307389000500316.","journal-title":"J Child Neurol"},{"key":"181_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/jnnp.46.6.551","volume":"46","author":"V Ionasescu","year":"1983","unstructured":"Ionasescu V, Searby C, Rubenstein P, Sandra A, Cancilla P, Robillard J: Giant axonal neuropathy: normal protein composition of neurofilaments. J Neurol Neurosurg Psychiatry. 1983, 46: 551-554. 10.1136\/jnnp.46.6.551.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"181_CR34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.brainresbull.2009.06.004","volume":"80","author":"R Perrot","year":"2009","unstructured":"Perrot R, Eyer J: Neuronal intermediate filaments and neurodegenerative disorders. Brain Res Bull. 2009, 80: 282-295. 10.1016\/j.brainresbull.2009.06.004.","journal-title":"Brain Res Bull"},{"key":"181_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/exnr.1999.7102","volume":"158","author":"MH Ko","year":"1999","unstructured":"Ko MH, Chen WP, Lin-Shiau SY, Hsieh ST: Age-dependent acrylamide neurotoxicity in mice: morphology, physiology, and function. Exp Neurol. 1999, 158: 37-46. 10.1006\/exnr.1999.7102.","journal-title":"Exp Neurol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1326-6-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T03:14:59Z","timestamp":1712373299000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/1750-1326-6-25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1186\/1750-1326-6-25","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,12]]},"assertion":[{"value":"28 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}